Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection
Clinical trial NCT03820258 · TERMINATED
Trial details
- NCT number
- NCT03820258
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-28
- Primary completion
- 2019-12-04
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.